The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 95-109

Bentham Science Publishers

Access to resources Recommend Favorite

The Recent Development of 7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2134-2151

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Strategies to Predict Effect of P-Glycoprotein Transporter Efflux and Minimize its Impact on the Penetration of Drugs into the Central Nervous System (CNS)

By  

Current Computer - Aided Drug Design, Vol. 4, Iss. 1, 2008-03 ,pp. : 67-75

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine A1 Receptor: Analysis of the Potential Therapeutic Effects Obtained by its Activation in the Central Nervous System

By  

Current Medicinal Chemistry, Vol. 9, Iss. 21, 2002-11 ,pp. : 1923-1937

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Cannabinoid System on Immune Modulation: Therapeutic Implications on CNS Inflammation

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 671-675

Bentham Science Publishers

Access to resources Recommend Favorite